Key result
Brief vagal stimulation applied either before ischemia or at the beginning of reperfusion reduced myocardial infarct size in mice by activating different protection mechanisms.
Why the study?
Does short-term vagal stimulation applied before ischemia or at the onset of reperfusion reduce myocardial infarct size in mice?
Does short-term vagal stimulation applied before ischemia or at the onset of reperfusion reduce myocardial infarct size in mice?
Short-term vagal stimulation applied before ischemia or at the onset of reperfusion reduces myocardial infarct size in mice via distinct receptor pathways.
Hypothesis-generating for timed vagal cardioprotection in mice; leaves open translation to clinical reperfusion strategies.
Vagal stimulation (VS) during myocardial ischemia and reperfusion has beneficial effects. However, it is not known whether short-term VS applied before ischemia or at the onset of reperfusion protects the ischemic myocardium. This study was designed to determine whether short-term VS applied before ischemia or at the onset of reperfusion reduces myocardial infarct size (IS), mimicking classic preconditioning and postconditioning. A second objective was to study the participation of muscarinic and nicotinic receptors in the protection of both preischemic and reperfusion stimulation. FVB mice were subjected to 30 min of regional myocardial ischemia followed by 2 h of reperfusion without VS, with 10-min preischemic VS (pVS), or with VS during the first 10 min of reperfusion (rVS). pVS reduced IS, and this effect was abolished by atropine and wortmannin. rVS also reduced IS in a similar manner, and this effect was abolished by the α 7 -nicotinic acetylcholine receptor blocker methyllycaconitine. pVS increased Akt and glycogen synthase kinase (GSK)-3β phosphorylation. No changes in Akt and GSK-3β phosphorylation were observed in rVS. Stimulation-mediated IS protection was abolished with the JAK2 blocker AG490. rVS did not modify IL-6 and IL-10 levels in the plasma or myocardium. Splenic denervation and splenectomy did not abolish the protective effect of rVS. In conclusion, pVS and rVS reduced IS by different mechanisms: pVS activated the Akt/GSK-3β muscarinic pathway, whereas rVS activated α 7 -nicotinic acetylcholine receptors and JAK2, independently of the cholinergic anti-inflammatory pathway. NEW & NOTEWORTHY Our data suggest, for the first time, that vagal stimulation applied briefly either before ischemia or at the beginning of reperfusion mimics classic preconditioning and postconditioning and reduces myocardial infarction, activating different mechanisms. We also infer an important role of α 7 -nicotinic receptors for myocardial protection independent of the cholinergic anti-inflammatory pathway.
No takes yet. Share an insight, caveat, or question.
Buchholz et al. (2018) studied Myocardial ischemia and reperfusion. Vagal stimulation vs. No vagal stimulation was evaluated on Myocardial infarct size. Brief vagal stimulation applied either before ischemia or at the beginning of reperfusion reduced myocardial infarct size in mice by activating different protection mechanisms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: